People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spectrum Antimicrobials, Inc. | — | Pharmaceuticals | Series A | $17.3M | $47.3M | 2020 |
Ronald H. Carli at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ronald H. Carli on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sameer Harish | 1 | 3 |
| Richard Zimmer | 1 | 3 |
| Hojabr Alimi | 1 | 3 |
| William H. Watson | 1 | 2 |
| Steven Henry Solferino | 1 | 1 |
| David Henry Allie | 1 | 1 |
| Ronald Henry Carli | 1 | 1 |
| Tchekanova Banafsheh | 1 | 1 |
| Jerry Henry Stonemetz | 1 | 1 |
| William Henry Watson III | 1 | 1 |
| Kate Lewis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.